246 related articles for article (PubMed ID: 22799316)
1. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
2. The BRAFT1799A mutation is not associated with occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Wan HF; Zhang B; Yan DG; Xu ZG
Asian Pac J Cancer Prev; 2015; 16(7):2947-51. PubMed ID: 25854387
[TBL] [Abstract][Full Text] [Related]
3. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
4. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Koo BS; Lim HS; Lim YC; Yoon YH; Kim YM; Park YH; Rha KS
Ann Surg Oncol; 2010 Apr; 17(4):1101-5. PubMed ID: 20066517
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features.
Lee YC; Eun YG; Sohn YM; Rhee SY; Hong IK; Chon S; Oh SJ; Kim DY
World J Surg; 2015 Jul; 39(7):1736-41. PubMed ID: 25743485
[TBL] [Abstract][Full Text] [Related]
6. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
8. How Many Contralateral Carcinomas in Patients with Unilateral Papillary Thyroid Microcarcinoma are Preoperatively Misdiagnosed as Benign?
Wu ZG; Yan XQ; Su RS; Ma ZS; Xie BJ; Cao FL
World J Surg; 2017 Jan; 41(1):129-135. PubMed ID: 27541032
[TBL] [Abstract][Full Text] [Related]
9. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
10. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
11. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
Zhang Q; Wang Z; Meng X; Duh QY; Chen G
Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
[TBL] [Abstract][Full Text] [Related]
12. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
13. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
14. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
15. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
[TBL] [Abstract][Full Text] [Related]
16. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
18. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
[TBL] [Abstract][Full Text] [Related]
20. Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.
So YK; Son YI; Park JY; Baek CH; Jeong HS; Chung MK
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):422-7. PubMed ID: 21750338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
